COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.

[1]  Chuan-Yun Li,et al.  A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation , 2021, Blood.

[2]  Luke H. Hoeppner,et al.  A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes. , 2021, Molecular cell.

[3]  Y. Miao,et al.  CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing , 2021, Molecular cancer.

[4]  P. Tan,et al.  “3G” Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy , 2021, Cancer Research.

[5]  Chi Zhou,et al.  Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer , 2020, Frontiers in Oncology.

[6]  Xi Chen,et al.  Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.

[7]  Taewan Kim,et al.  A-to-I RNA editing as a tuner of noncoding RNAs in cancer. , 2020, Cancer letters.

[8]  R. Greil,et al.  RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia , 2020, Leukemia.

[9]  T. Molina,et al.  Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling , 2020, The Journal of experimental medicine.

[10]  Henry Yang,et al.  RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. , 2020, Journal of hepatology.

[11]  Christopher S. Law,et al.  A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome , 2020, bioRxiv.

[12]  P. Hegde,et al.  Top 10 Challenges in Cancer Immunotherapy. , 2020, Immunity.

[13]  D. Baltimore,et al.  Alternative mRNA splicing in cancer immunotherapy , 2019, Nature Reviews Immunology.

[14]  Kazuhiro Yoshida,et al.  Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer. , 2019, Cancer letters.

[15]  Lieping Chen,et al.  A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization , 2018, Cell.

[16]  G. Mills,et al.  RNA editing derived epitopes function as cancer antigens to elicit immune responses , 2018, Nature Communications.

[17]  Y. Takagi,et al.  A protein–protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme , 2018, Nucleic acids research.

[18]  H. Fuchs,et al.  RNA editing of Filamin A pre‐mRNA regulates vascular contraction and diastolic blood pressure , 2018, The EMBO journal.

[19]  Jacob Silterra,et al.  Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab , 2018, Nature Medicine.

[20]  Leng Han,et al.  A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer. , 2018, Cancer cell.

[21]  Eli Eisenberg,et al.  A-to-I RNA editing — immune protector and transcriptome diversifier , 2018, Nature Reviews Genetics.

[22]  E. Levanon,et al.  Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus , 2018, Cell reports.

[23]  Hua Tang,et al.  Regulation of gene expression and RNA editing in Drosophila adapting to divergent microclimates , 2017, Nature Communications.

[24]  R. Unger,et al.  RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure , 2017, Nature Communications.

[25]  Patricia Deng,et al.  The evolution and adaptation of A-to-I RNA editing , 2017, PLoS genetics.

[26]  K. Stellos,et al.  Adenosine-to-Inosine RNA Editing in Health and Disease. , 2017, Antioxidants & redox signaling.

[27]  X. Zuo,et al.  RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer , 2017, Proceedings of the National Academy of Sciences.

[28]  G. Fimia,et al.  Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate , 2017, Front. Oncol..

[29]  L. Crews,et al.  RNA editing-dependent epitranscriptome diversity in cancer stem cells , 2017, Nature Reviews Cancer.

[30]  Xueda Hu,et al.  RNA editing is induced by type I interferon in esophageal squamous cell carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[31]  Michael R. Johnson,et al.  Genome-wide analysis of differential RNA editing in epilepsy. , 2017, Genome research.

[32]  Tae-You Kim,et al.  Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[33]  N. Davidson,et al.  RNA Editing: Another Level of Somatic Mutagenic Activity in Gastric Cancer. , 2016, Gastroenterology.

[34]  D. Tenen,et al.  ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. , 2016, Gastroenterology.

[35]  H. Schwalbe,et al.  Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation , 2016, Nature Medicine.

[36]  Ran Tao,et al.  Dynamic regulation of RNA editing in human brain development and disease , 2016, Nature Neuroscience.

[37]  Hugh Thomas.  Gastric cancer: Dysregulation of RNA editing in gastric cancer , 2016, Nature Reviews Gastroenterology &Hepatology.

[38]  P. Hegde,et al.  The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition , 2016, Clinical Cancer Research.

[39]  Stefano Monti,et al.  Altered RNA editing in 3′ UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors , 2016, Scientific Reports.

[40]  G. Mills,et al.  The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. , 2015, Cancer cell.

[41]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[42]  Mark S. Anderson,et al.  COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis , 2015, Nature Genetics.

[43]  H. Kato,et al.  Stress Responses from the Endoplasmic Reticulum in Cancer , 2015, Front. Oncol..

[44]  David Gacquer,et al.  Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome , 2015, bioRxiv.

[45]  Jeong-Sun Seo,et al.  Abstract 5189: RNA editing in rhoq promotes invasion potential in colorectal cancer , 2014 .

[46]  F. Brandizzi,et al.  Organization of the ER–Golgi interface for membrane traffic control , 2013, Nature Reviews Molecular Cell Biology.

[47]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[48]  C. Hetz.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.

[49]  N. Amariglio,et al.  Increased RNA editing in children with cyanotic congenital heart disease , 2011, Intensive Care Medicine.

[50]  Y. Oike,et al.  Endoplasmic Reticulum Stress-Related Inflammation and Cardiovascular Diseases , 2011, International journal of inflammation.

[51]  Xiaohua Shen,et al.  The unfolded protein response in nutrient sensing and differentiation , 2002, Nature Reviews Molecular Cell Biology.

[52]  M. O’Connell,et al.  The many roles of an RNA editor , 2001, Nature Reviews Genetics.

[53]  K. Nishikura,et al.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. , 2000, RNA.

[54]  H. Riezman,et al.  Alpha-COP can discriminate between distinct, functional di-lysine signals in vitro and regulates access into retrograde transport. , 1998, Journal of cell science.

[55]  S. Emr,et al.  Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum , 1994, Cell.

[56]  T. Rapoport.  Transport of proteins across the endoplasmic reticulum membrane. , 1992, Science.

[57]  Y. Nishimoto,et al.  Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis. , 2010, Journal of pharmacological sciences.